Cost Paramount When Choosing Metastatic Breast Cancer Treatment Cost Paramount When Choosing Metastatic Breast Cancer Treatment

Differences in outcomes and quality of life across commonly used treatments for endocrine-refractory and triple-negative metastatic breast cancer were"razor-thin," leaving cost as a key factor.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news